Bio-Techne Corporation (TECH) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TECH Revenue Growth
Revenue Breakdown (FY 2025)
TECH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
TECH Revenue Analysis (2014–2025)
As of May 8, 2026, Bio-Techne Corporation (TECH) generated trailing twelve-month (TTM) revenue of $1.21 billion, reflecting slight decline in growth of -1.5% year-over-year. The most recent quarter (Q3 2026) recorded $311.4 million in revenue, up 5.3% sequentially.
Looking at the longer-term picture, TECH's 5-year compound annual growth rate (CAGR) stands at +10.5%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $1.22 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows TECH's business is primarily driven by Consumables (88%), Instruments (10%), and Royalty (2%). With over half of revenue concentrated in Consumables, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including RGEN (+17.4% YoY), NEOG (-3.7% YoY), and AZTA (+1.8% YoY), TECH has underperformed the peer group in terms of revenue growth. Compare TECH vs RGEN →
TECH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TECHCurrent | $1.2B | -1.5% | +10.5% | 8.4% | |
 RGEN | $738M | +17.4% | +15.0% | 8.1% | |
 NEOG | $895M | -3.7% | +16.4% | 1.1% | |
 AZTA | $594M | +1.8% | +8.9% | -1.9% | |
 RVTY | $2.9B | +4.8% | -5.5% | 12.5% | |
 MESO | $17M | +191.4% | -11.8% | -363.1% |
TECH Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.22B | +5.2% | $790.3M | 64.8% | $102.3M | 8.4% |
| 2024 | $1.16B | +2.0% | $769.7M | 66.4% | $206.7M | 17.8% |
| 2023 | $1.14B | +2.8% | $769.8M | 67.7% | $298.9M | 26.3% |
| 2022 | $1.11B | +18.7% | $756.5M | 68.4% | $296.6M | 26.8% |
| 2021 | $931.0M | +26.0% | $632.9M | 68.0% | $237.3M | 25.5% |
| 2020 | $738.7M | +3.5% | $483.2M | 65.4% | $157.4M | 21.3% |
| 2019 | $714.0M | +11.0% | $473.5M | 66.3% | $125.6M | 17.6% |
| 2018 | $643.0M | +14.2% | $432.1M | 67.2% | $136.2M | 21.2% |
| 2017 | $563.0M | +12.8% | $374.5M | 66.5% | $121.8M | 21.6% |
| 2016 | $499.0M | +10.3% | $336.7M | 67.5% | $150.6M | 30.2% |
See TECH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TECH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TECH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTECH — Frequently Asked Questions
Quick answers to the most common questions about buying TECH stock.
Is TECH's revenue growth accelerating or slowing?
TECH revenue growth slowed to -1.5%, below the 5-year CAGR of +10.5%. TTM revenue is $1.2B. The deceleration marks a shift from historical growth rates.
What is TECH's long-term revenue growth rate?
Bio-Techne Corporation's 5-year revenue CAGR of +10.5% reflects the variable expansion pattern. Current YoY growth of -1.5% is near this long-term average.
How is TECH's revenue distributed by segment?
TECH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.